Abstract
Quantitative structure-activity relationships (QSAR) are one of the most important methodologies for rational drug design. In QSAR, compounds are represented by chemical structure descriptors, and then statistical models are built to predict biological activities of candidate structures. In this paper, two principal topics in QSAR, variable selection and 3D-QSAR, are picked up and are reviewed in recent trend. The aim of variable selection is to construct a significant QSAR model by selecting important descriptors among from descriptor pool. Until now, many variable selection methods have been developed and proposed. On the other hand, molecular alignment is important factor of 3D-QSAR analysis because appropriate alignment is usually required to construct proper 3D-QSAR models. In addition, we review new QSAR methods using molecular surface properties, alignment independent QSAR methods, and 4D-QSAR methods.
Keywords: QSAR, variable selection, 3D-QSAR, molecular alignment, genetic algorithm, genetic programming
Current Computer-Aided Drug Design
Title: The Recent Trend in QSAR Modeling - Variable Selection and 3D-QSAR Methods
Volume: 3 Issue: 4
Author(s): Masamoto Arakawa, Kiyoshi Hasegawa and Kimito Funatsu
Affiliation:
Keywords: QSAR, variable selection, 3D-QSAR, molecular alignment, genetic algorithm, genetic programming
Abstract: Quantitative structure-activity relationships (QSAR) are one of the most important methodologies for rational drug design. In QSAR, compounds are represented by chemical structure descriptors, and then statistical models are built to predict biological activities of candidate structures. In this paper, two principal topics in QSAR, variable selection and 3D-QSAR, are picked up and are reviewed in recent trend. The aim of variable selection is to construct a significant QSAR model by selecting important descriptors among from descriptor pool. Until now, many variable selection methods have been developed and proposed. On the other hand, molecular alignment is important factor of 3D-QSAR analysis because appropriate alignment is usually required to construct proper 3D-QSAR models. In addition, we review new QSAR methods using molecular surface properties, alignment independent QSAR methods, and 4D-QSAR methods.
Export Options
About this article
Cite this article as:
Arakawa Masamoto, Hasegawa Kiyoshi and Funatsu Kimito, The Recent Trend in QSAR Modeling - Variable Selection and 3D-QSAR Methods, Current Computer-Aided Drug Design 2007; 3 (4) . https://dx.doi.org/10.2174/157340907782799417
DOI https://dx.doi.org/10.2174/157340907782799417 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapy Against Ischemic Injury
Current Pharmaceutical Design Association of Lipoprotein-associated Phospholipase A2 Activity with Components of the Metabolic Syndrome in Apparently Healthy Boys
Cardiovascular & Hematological Agents in Medicinal Chemistry Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Current Topics in Medicinal Chemistry Recent Advances in the Study of Glycosphingolipids
Current Pharmaceutical Biotechnology Inhibitors of Phosphoinositol 3 Kinase and NFκB for the Treatment of Chronic Obstructive Pulmonary Disease
Recent Patents on Inflammation & Allergy Drug Discovery Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease
Current Neuropharmacology Safflor Protected Rat Cerebral Ischemia-Reperfusion Injury Through Inhibiting the Expression of NF-kB and IL-1β
Neuroscience and Biomedical Engineering (Discontinued) Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome
Current Pharmaceutical Design <i>In Silico</i> Design of a Novel Multi-Epitope Peptide Vaccine Against Hepatocellular Carcinoma
Letters in Drug Design & Discovery Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Current Cancer Drug Targets Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
Current Diabetes Reviews Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Current Gene Therapy The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) COX-2 Inhibition, Apoptosis, and Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.
Current Medicinal Chemistry Experimental Benefits of Sex Hormones on Vascular Function and the Outcome of Hormone Therapy in Cardiovascular Disease
Current Cardiology Reviews Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
Current Pharmaceutical Design Novel Targets in Multiple Sclerosis: To Oxidative Stress and Beyond
Current Topics in Medicinal Chemistry Biologic Therapies Against Inflammatory Bowel Disease: A Dysregulated Immune System and the Cross Talk with Gastrointestinal Mucosa Hold the Key
Current Molecular Pharmacology Hypoxia and Oxidative Stress in the Causation of Diabetic Retinopathy
Current Diabetes Reviews Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
Current Molecular Medicine